Hepatic PEPCK and G6Pase mRNA expressions were significantly higher (Fig. 1c, d), while GCK mRNA expression tended to be higher, in the SS and NASH groups than in the controls (Fig. 1e). This evidence concerns the gene G6PC1 and metabolic dysfunction-associated steatohepatitis.